Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Chairperson's Opening Remarks
Process Intensification
Development of Next Generation Purification Platforms through Novel Technologies and Holistic Process Engineering Approaches. Speakers would address process intensification as part of next generation bioprocess strategy. In the current environment of diverse product pipelines, rapidly fluctuating market demands and growing competition from biosimilars, companies are driven to develop innovative solutions for highly flexible and cost‐effective processes and manufacturing. To address these challenging demands, integrated continuous processing, comprised of high‐density perfusion cell culture and a directly coupled with continuous capture step, can be used as a universal Biomanufacturing platform.
Area of Focus
Confirmed Speakers:
Kumar Dhanasekharan - Amicus Therapeutics
Alexei Voloshin - 3M
Hiren Ardeshna - GSK
Andrew Tustian - Regeneron
Antonio Ubiera - GSK
Rajesh Beri - Lonza
Sigma Mostafa - KBI
Benoit Mothes - Sanofi
Round table